Alvotech (ALVO) vs Eton Pharmaceuticals, Inc. (ETON)
Alvotech and Eton Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Alvotech is the larger, with a market value of $2.3B against $1.7B — 1.3× the size. Alvotech has negative trailing earnings, so its P/E is not meaningful; Eton Pharmaceuticals, Inc. trades at 123×. Alvotech grew revenue faster over the last twelve months: 364.3% against 81.5%. Eton Pharmaceuticals, Inc. has the higher net margin (12.0% vs −101.1%) and the higher return on invested capital (21.4% vs 0.00%). Across the 16 metrics below, Eton Pharmaceuticals, Inc. leads on 9 and Alvotech on 7.
Valuation
Profitability
| Metric | ALVO | ETON | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 42.71% | 57.87% | 53.94% |
| Operating margin | (42.43%) | 15.44% | 0.00% |
| Net margin | (101.05%) | 12.02% | 0.00% |
| Free cash flow margin | 0.00% | (7.94%) | 0.00% |
| Return on equity | 0.00% | 35.97% | (0.40%) |
| Return on assets | 0.00% | 11.67% | (3.32%) |
| Return on invested capital | 0.00% | 21.39% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack